share_log

Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket

Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket

爲甚麼 Entrada Therapeutics 股票的交易價格下跌了 32%;以下是 31 只股票盤前走勢
Benzinga Real-time News ·  2022/12/20 06:15
Gainers
獲勝者
IceCure Medical Ltd (NASDAQ:ICCM) shares rose 158% to $2.42 in pre-market trading after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who cannot be offered kidney-preserving surgery. Exicure, Inc. (NASDAQ:XCUR) shares rose 46% to $1.08 in pre-market trading. Exicure 10% owner CBI USA, Inc. acquired a total of 3,400,000 shares at an average price of $1.60. Verona Pharma plc (NASDAQ:VRNA) rose 39.3% to $18.80 in pre-market trading after the company reported positive results of its Phase 3 ENHANCE-1 trial evaluating nebulized ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease. Otonomy...
iCecure 醫療有限公司 納斯達克股票代碼:ICCM)的股價在盤前交易中上漲了158%,至2.42美元,此前該公司公佈了ICESECRET研究的中期結果,該研究旨在治療無法接受腎臟保存手術的小腎...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論